R.SikesJ
Al-Musharaf S, Alabdulaaly A, Bin Mujalli H, Alshehri H, Alajaji H, Bogis R
Maximum Responder Rate (20%+ Loss)# Recommendation : CagriSema Reason : 60% of CagriSema patients achieved at least 20% weight loss in REDEFINE 1, a higher responder rate than tirzepatide's across-trial data, though cross-trial comparison has limitations
As early as the 1940s, researchers connected the evidence of B vitamin deficiency with gynecological disorders
(2009) Effectiveness of vitamin B12 in treating recurrent aphthous stomatitis: a randomized, double-blind, placebo-controlled trial
Clinical trials show moderate evidence for pain reduction over 8 to 24 weeks, particularly in aging populations